bemethyl has been researched along with Myotonic-Dystrophy* in 2 studies
1 trial(s) available for bemethyl and Myotonic-Dystrophy
| Article | Year |
|---|---|
[Mechanisms of the therapeutic effect of bemitil in neuromuscular diseases].
Studies into the mechanism of the therapeutic action of bemitil were carried out in 21 patients with neuromuscular diseases. Measurements of lipid peroxidation and permeability of the erythrocytic membranes demonstrated the drug to influence carbohydrate and lipid metabolism, lipid peroxidation, and permeability of the cellular membranes. It is recommended that bemitil be used for the treatment of neuromuscular diseases. Topics: Adolescent; Adult; Antioxidants; Benzimidazoles; Erythrocytes; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Muscular Dystrophies; Myotonic Dystrophy | 1991 |
1 other study(ies) available for bemethyl and Myotonic-Dystrophy
| Article | Year |
|---|---|
[The use of bemitil in patients with progressive muscular dystrophies].
Bemithyl treatment was carried out in 22 patients with neuromuscular diseases (progressive myodystrophy). The actoprotector bemithyl inhibited in these patients the processes of lipid peroxidation, activation of neoglucogenesis favours improvement of interorganic exchange of metabolites. Bemithyl is recommended in patients with progressive myodystrophy along with drugs normalizing the protein, energy and electrolyte metabolism. Topics: Adolescent; Adult; Antioxidants; Benzimidazoles; Drug Evaluation; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Muscular Dystrophies; Myotonic Dystrophy; Syndrome | 1992 |